ETopical – Lifestyle

Author: Ascelia Pharma

Change in Number of Shares and Votes in Ascelia Pharma AB

April 30, 2026
Annual Report 2025: Orviglance NDA submitted to the FDA, PDUFA-date set for July 2026

April 9, 2026
Notice of Annual General Meeting in Ascelia Pharma AB

March 30, 2026
Ascelia Pharma Announces Acceptance of Orviglance Data for Oral Presentation at the Annual Radiology Congress ESGAR 2026

March 27, 2026